During the past decade, CCBR Aalborg conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCBR Aalborg" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Nordic Bioscience A/S" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Biogen" with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR Aalborg" #1 collaborator was "Novartis" with 3 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "CCBR Clinical Research" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "CCBR Aalborg" are "Osteoarthritis" (4 trials), "Alzheimer's Disease" (3 trials), "Dyslipidemia" (3 trials), "Cardiovascular Disease" (2 trials) and "Type II Diabetes Mellitus" (2 trials). Many other conditions were trialed in "CCBR Aalborg" in a lesser frequency.

Most popular intervention types in "CCBR Aalborg" are "Drug" (18 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Pitavastatin" (3 trials), "Atorvastatin" (2 trials), "SMC021 Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "CCBR Aalborg" are 17 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CCBR Aalborg". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in CCBR Aalborg, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CCBR Aalborg, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".